Rapid boosting of HIV-1 neutralizing antibody responses in humans following a prolonged immunologic rest period.
Spearman, P; Tomaras, GD; Montefiori, DC; Huang, Y; Elizaga, ML; Ferrari, G; Munir Alam, S; Isaacs, A; Ahmed, H; Hural, J; et al.
Journal of Infectious Diseases.
2019;
219:1755-1765.
Challenges and solutions for instituting an efficient maintenance program for laboratory equipment in Central Asian, and developing world, countries.
Ikranbegiin, R; Schmid, G; Hoos, D; Young, A; Della-Latta, P; Spearman, P; Ramos, A; Alemayehu, B; Achmetova, B; Nauryzova, G; et al.
BMC Public Health.
2019;
19.
The ability of SAMHD1 to block HIV-1 but not SIV requires expression of MxB.
Buffone, C; Kutzner, J; Opp, S; Martinez-Lopez, A; Selyutina, A; Coggings, SA; Studdard, LR; Ding, L; Kim, B; Spearman, P; et al.
Virology.
2019;
531:260-268.
DNA vaccine priming for seasonal influenza vaccine in children and adolescents 6 to 17 years of age: A phase 1 randomized clinical trial.
Houser, KV; Yamshchikov, GV; Bellamy, AR; May, J; Enama, ME; Sarwar, U; Larkin, B; Bailer, RT; Koup, R; Paskel, M; et al.
PLoS ONE.
2018;
13:e0206837-e0206837.
A novel Ebola virus antibody-dependent cell-mediated cytotoxicity (Ebola ADCC) assay.
Singh, K; Marasini, B; Chen, X; Spearman, P.
Journal of Immunological Methods.
2018;
460:10-16.
Targeted Elimination of Tumorigenic Human Pluripotent Stem Cells Using Suicide-Inducing Virus-like Particles.
Rampoldi, A; Crooke, SN; Preininger, MK; Jha, R; Maxwell, J; Ding, L; Spearman, P; Finn, MG; Xu, C.
ACS Chemical Biology.
2018;
13:2329-2338.
HIV-1 Envelope Glycoprotein Trafficking through the Endosomal Recycling Compartment Is Required for Particle Incorporation.
Kirschman, J; Qi, M; Ding, L; Hammonds, J; Dienger-Stambaugh, K; Wang, J; Lapierre, LA; Goldenring, JR; Spearman, P.
Journal of Virology.
2018;
92.
HIV-1 decreases Nrf2/ARE activity and phagocytic function in alveolar macrophages.
Staitieh, BS; Ding, L; Neveu, WA; Spearman, P; Guidot, DM; Fan, X.
Journal of Leukocyte Biology.
2017;
102:517-525.
Adjuvanting a simian immunodeficiency virus vaccine with toll-like receptor ligands encapsulated in nanoparticles induces persistent antibody responses and enhanced protection in trim5α restrictive macaques.
Kasturi, SP; Kozlowski, PA; Nakaya, HI; Burger, MC; Russo, P; Pham, M; Kovalenkov, Y; Silveira, EL V; Havenar-Daughton, C; Burton, SL; et al.
Journal of Virology.
2017;
91.
HIV-related proteins prolong macrophage survival through induction of Triggering receptor expressed on myeloid cells-1.
Yuan, Z; Fan, X; Staitieh, B; Bedi, C; Spearman, P; Guidot, DM; Sadikot, RT.
Scientific Reports.
2017;
7.